United States Healthcare Providers & Services

Neogenomics Inc (NEO)

Track

Track

Neogenomics Inc. experienced seven insider trading transactions recently, totaling approximately 4.58 million dollars in sales. These divestments occurred following a strong 59.5% stock price increase over ninety days. Executives and directors executed these disposals shortly after the company reported positive results financiers, beating earnings expectations by 83.33%.
Ticker: NEO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Neogenomics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Aunan Greg D Chief Accounting Officer Officer
Transaction date
Sale
Price
102.18
Quantity 84,443 +9.9%
Value US$2,733,473
GREG AUNAN Officer; Director Executive Director
Transaction date
Proposed sale
Price
285.23
Quantity 45,874
Value US$242,545
3.4
JEFFREY SHERMAN Former Affliate
Transaction date
Proposed sale
Price
495.41
Quantity 40,976
Value US$991,214
2.7
TETRAULT LYNN A. Non-Executive Director
Transaction date
Sale
Price
11.10
Quantity 5,307 -5.8%
Value US$58,908
2.7
LYNN TETRAULT Director Non-Executive Director
Transaction date
Proposed sale
Price
11.15
Quantity 5,307
Value US$59,173
2.7
TETRAULT LYNN A. Non-Executive Director
Transaction date
Sale
Price
11.29
Quantity 5,307 -5.5%
Value US$59,916
2.7
LYNN TETRAULT Director Non-Executive Director
Transaction date
Proposed sale
Price
10.95
Quantity 5,307
Value US$58,112
2.9
Stone Warren Pres & Chief Operating Officer Officer
Transaction date
Sale
Price
12.50
Quantity 22,128 -15.4%
Value US$276,682
2.9
WARREN STONE Officer Officer
Transaction date
Proposed sale
Price
12.79
Quantity 22,128
Value US$283,017
1.8
Olivo Alicia C EVP, GC & Business Development Officer
Transaction date
Planned sale
Price
12.00
Quantity 20,916 -40.2%
Value US$250,992
1.8
ALICIA OLIVO Officer Officer
Transaction date
Proposed sale
Price
11.61
Quantity 11,939
Value US$138,612
1.8
Olivo Alicia C EVP, GC & Business Development Officer
Transaction date
Planned sale
Price
10.00
Quantity 4,918 -10.3%
Value US$49,180
1.8
ALICIA OLIVO Officer Officer
Transaction date
Proposed sale
Price
9.97
Quantity 4,918
Value US$49,032
3.4
Sherman Jeffrey Scott Chief Financial Officer Officer
Transaction date
Purchase
Price
5.62
Quantity 20,000 +11.9%
Value US$112,322
3.1
Zook Anthony P. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.58
Quantity 17,900 +88.8%
Value US$99,954
1.4
Kelly Michael Aaron Non-Executive Director
Transaction date
Purchase
Price
7.60
Quantity 5,000 +inf%
Value US$38,000
2.9
Stone Warren Pres & Chief Operating Officer Officer
Transaction date
Purchase
Price
8.58
Quantity 5,700 +5.6%
Value US$48,895
2.7
TETRAULT LYNN A. Non-Executive Director
Transaction date
Purchase
Price
8.14
Quantity 7,000 +inf%
Value US$56,974
1.4
KANOVSKY STEPHEN M Non-Executive Director
Transaction date
Purchase
Price
7.78
Quantity 4,000 +11.1%
Value US$31,124
3.1
Zook Anthony P. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
7.88
Quantity 18,900 +inf%
Value US$148,919
1.5
Perez David Brian Non-Executive Director
Transaction date
Purchase
Price
7.63
Quantity 10,000 +inf%
Value US$76,300
1.5
Gunn Neil Non-Executive Director
Transaction date
Purchase
Price
7.76
Quantity 4,510 +39.8%
Value US$34,977
3.4
Sherman Jeffrey Scott Chief Financial Officer Officer
Transaction date
Planned purchase
Price
7.51
Quantity 20,000 +14.4%
Value US$150,104
1.8
Olivo Alicia C General Counsel Officer
Transaction date
Planned sale
Price
15.36
Quantity 5,175 -12.2%
Value US$79,475
1.8
ALICIA OLIVO Officer Officer
Transaction date
Proposed sale
Price
15.79
Quantity 5,175
Value US$81,713
1.8
Olivo Alicia C General Counsel Officer
Transaction date
Planned sale
Price
16.05
Quantity 1,040 -2.3%
Value US$16,695
1.8
ALICIA OLIVO Officer Officer
Transaction date
Proposed sale
Price
15.82
Quantity 1,040
Value US$16,453
1.7
BRUCE K CROWTHER Officer; Director Executive Director
Transaction date
Proposed sale
Price
15.95
Quantity 8,353
Value US$133,243
1.7
BRUCE K CROWTHER Officer; Director Executive Director
Transaction date
Proposed sale
Price
14.29
Quantity 13,882
Value US$198,336
1.8
Olivo Alicia C General Counsel Officer
Transaction date
Sale
Price
15.74
Quantity 1,049 -2.3%
Value US$16,511
1.8
ALICIA OLIVO Officer Officer
Transaction date
Proposed sale
Price
15.40
Quantity 1,049
Value US$16,155
2.7
TETRAULT LYNN A. Non-Executive Director
Transaction date
Sale
Price
15.97
Quantity 6,112 -10.9%
Value US$97,579
2.7
LYNN TETRAULT Director Non-Executive Director
Transaction date
Proposed sale
Price
15.97
Quantity 6,112
Value US$97,609
1.8
Olivo Alicia C General Counsel Officer
Transaction date
Planned sale
Price
14.96
Quantity 2,587 -6.9%
Value US$38,713
1.8
ALICIA OLIVO Officer Officer
Transaction date
Proposed sale
Price
14.90
Quantity 2,587
Value US$38,546
1.8
Olivo Alicia C General Counsel Officer
Transaction date
Planned sale
Price
18.39
Quantity 2,669 -6.7%
Value US$49,083
1.8
ALICIA OLIVO Officer Officer
Transaction date
Proposed sale
Price
17.97
Quantity 2,669
Value US$47,962
2.0
Bonello William Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.29
Quantity 3,209 -3.2%
Value US$58,693
McKenzie Kathryn B Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.00
Quantity 1,846 -13.6%
Value US$64,610
0.7
Mallon Mark Chief Executive Officer Executive Director
Transaction date
Purchase
Price
30.63
Quantity 17,000 +30.5%
Value US$520,710
Brown Douglas Matthew Chief Strategy Officer Officer
Transaction date
Planned sale
Price
36.85
Quantity 33,334 -74.1%
Value US$1,228,358
2.0
Bonello William President, Informatics Officer
Transaction date
Planned sale
Price
37.13
Quantity 25,000 -61.8%
Value US$928,250
Brown Douglas Matthew Chief Strategy Officer Officer
Transaction date
Planned sale
Price
36.84
Quantity 33,333 -42.6%
Value US$1,227,988
Brown Douglas Matthew Chief Strategy Officer Officer
Transaction date
Planned sale
Price
37.19
Quantity 33,333 -29.9%
Value US$1,239,654
1.7
CROWTHER BRUCE K Non-Executive Director
Transaction date
Sale
Price
41.46
Quantity 20,734 -29.5%
Value US$859,632
2.1
CARDOZA GEORGE President, Pharma Services Officer
Transaction date
Sale
Price
40.11
Quantity 31,107 -15.0%
Value US$1,247,702
2.1
CARDOZA GEORGE President, Pharma Services Officer
Transaction date
Sale
Price
40.39
Quantity 169,230 -44.9%
Value US$6,835,200
2.0
Weiss Lawrence Martin Chief Medical Officer Officer
Transaction date
Sale
Price
51.06
Quantity 20,200 -16.7%
Value US$1,031,412
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
51.67
Quantity 25,000 -2.4%
Value US$1,291,750
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
50.52
Quantity 25,000 -2.4%
Value US$1,263,000
2.3
BALLIET JENNIFER VP and Chief Culture Officer Officer
Transaction date
Sale
Price
49.99
Quantity 15,000 -37.5%
Value US$749,850
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
50.30
Quantity 20,000 -1.9%
Value US$1,006,000
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
49.45
Quantity 45,658 -4.1%
Value US$2,257,788
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
48.07
Quantity 64,394 -5.5%
Value US$3,095,420
1.5
Johnson Kevin C Non-Executive Director
Transaction date
Sale
Price
47.88
Quantity 24,683 -44.3%
Value US$1,181,822
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
48.03
Quantity 19,948 -1.7%
Value US$958,102
2.0
Bonello William President, Informatics Officer
Transaction date
Sale
Price
46.80
Quantity 8,000 -39.9%
Value US$374,400
2.1
CARDOZA GEORGE President, Pharma Services Officer
Transaction date
Sale
Price
45.48
Quantity 77,074 -17.2%
Value US$3,505,326
2.1
CARDOZA GEORGE President, Pharma Services Officer
Transaction date
Sale
Price
45.19
Quantity 52,926 -12.5%
Value US$2,391,726
1.4
HIPP RAYMOND R Non-Executive Director
Transaction date
Sale
Price
42.28
Quantity 70,000 -51.2%
Value US$2,959,600
0.9
VAN OORT DOUGLAS M Chairman and CEO Executive Director
Transaction date
Sale
Price
42.34
Quantity 100,000 -4.0%
Value US$4,234,000
0.9
VAN OORT DOUGLAS M Chairman and CEO Executive Director
Transaction date
Sale
Price
41.56
Quantity 118,752 -4.5%
Value US$4,935,333
0.9
VAN OORT DOUGLAS M Chairman and CEO Executive Director
Transaction date
Sale
Price
42.18
Quantity 121,248 -5.1%
Value US$5,114,241
0.6
Pedulla Denise E General Counsel Officer
Transaction date
Sale
Price
42.00
Quantity 2,262 -3.8%
Value US$95,004
1.7
CROWTHER BRUCE K Non-Executive Director
Transaction date
Sale
Price
35.01
Quantity 8,333 -15.2%
Value US$291,738
1.7
CROWTHER BRUCE K Non-Executive Director
Transaction date
Sale
Price
35.68
Quantity 2,400 -4.9%
Value US$85,632
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
37.13
Quantity 37,991 -2.7%
Value US$1,410,606
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
36.98
Quantity 71,583 -4.8%
Value US$2,647,139
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
36.13
Quantity 10,426 -0.7%
Value US$376,691
2.1
CARDOZA GEORGE President, Pharma Services Officer
Transaction date
Sale
Price
39.35
Quantity 82,500 -19.0%
Value US$3,246,375
2.0
Bonello William President, Informatics Officer
Transaction date
Sale
Price
38.61
Quantity 22,000 -64.6%
Value US$849,420
2.3
BALLIET JENNIFER VP and Chief Culture Officer Officer
Transaction date
Sale
Price
39.25
Quantity 13,000 -34.2%
Value US$510,250
2.4
SHOVLIN ROBERT J. President, Clinical Services Officer
Transaction date
Sale
Price
38.17
Quantity 81,356 -35.4%
Value US$3,105,359
2.4
SHOVLIN ROBERT J. President, Clinical Services Officer
Transaction date
Sale
Price
30.86
Quantity 98,093 -39.3%
Value US$3,027,150
2.6
JONES STEVEN C Non-Executive Director
Transaction date
Sale
Price
28.24
Quantity 20,000 -39.6%
Value US$564,800
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-06 2026-08-04 S Sale
Aunan Greg D

Chief Accounting Officer

Officer
84,443 +9.9%
102.18
US$2,733,473 		84,443 +9.9% 102.18 US$2,733,473
2026-08-04 2026-08-04 PrS Proposed sale
GREG AUNAN

Officer; Director

Executive Director
45,874
285.23
US$242,545 		45,874 285.23 US$242,545
2026-07-30 2026-07-30 PrS Proposed sale
3.4
JEFFREY SHERMAN

Former Affliate
40,976
495.41
US$991,214 		40,976 495.41 US$991,214
2026-06-17 2026-06-15 S Sale
2.7
TETRAULT LYNN A.
Non-Executive Director
5,307 -5.8%
11.10
US$58,908 		5,307 -5.8% 11.10 US$58,908
2026-06-15 2026-06-15 PrS Proposed sale
2.7
LYNN TETRAULT

Director

Non-Executive Director
5,307
11.15
US$59,173 		5,307 11.15 US$59,173
2026-06-11 2026-06-09 S Sale
2.7
TETRAULT LYNN A.
Non-Executive Director
5,307 -5.5%
11.29
US$59,916 		5,307 -5.5% 11.29 US$59,916
2026-06-09 2026-06-09 PrS Proposed sale
2.7
LYNN TETRAULT

Director

Non-Executive Director
5,307
10.95
US$58,112 		5,307 10.95 US$58,112
2026-01-21 2026-01-20 S Sale
2.9
Stone Warren

Pres & Chief Operating Officer

Officer
22,128 -15.4%
12.50
US$276,682 		22,128 -15.4% 12.50 US$276,682
2026-01-20 2026-01-20 PrS Proposed sale
2.9
WARREN STONE

Officer

Officer
22,128
12.79
US$283,017 		22,128 12.79 US$283,017
2025-11-28 2025-11-25 PlS Planned sale
1.8
Olivo Alicia C

EVP, GC & Business Development

Officer
20,916 -40.2%
12.00
US$250,992 		20,916 -40.2% 12.00 US$250,992
2025-11-25 2025-11-25 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
11,939
11.61
US$138,612 		11,939 11.61 US$138,612
2025-10-20 2025-10-16 PlS Planned sale
1.8
Olivo Alicia C

EVP, GC & Business Development

Officer
4,918 -10.3%
10.00
US$49,180 		4,918 -10.3% 10.00 US$49,180
2025-10-16 2025-10-16 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
4,918
9.97
US$49,032 		4,918 9.97 US$49,032
2025-08-06 2025-08-06 B Purchase
3.4
Sherman Jeffrey Scott

Chief Financial Officer

Officer
20,000 +11.9%
5.62
US$112,322 		20,000 +11.9% 5.62 US$112,322
2025-08-06 2025-08-06 B Purchase
3.1
Zook Anthony P.

Chief Executive Officer

Executive Director
17,900 +88.8%
5.58
US$99,954 		17,900 +88.8% 5.58 US$99,954
2025-05-28 2025-05-27 B Purchase
1.4
Kelly Michael Aaron
Non-Executive Director
5,000 +inf%
7.60
US$38,000 		5,000 +inf% 7.60 US$38,000
2025-05-13 2025-05-12 B Purchase
2.9
Stone Warren

Pres & Chief Operating Officer

Officer
5,700 +5.6%
8.58
US$48,895 		5,700 +5.6% 8.58 US$48,895
2025-05-09 2025-05-09 B Purchase
2.7
TETRAULT LYNN A.
Non-Executive Director
7,000 +inf%
8.14
US$56,974 		7,000 +inf% 8.14 US$56,974
2025-05-09 2025-05-07 B Purchase
1.4
KANOVSKY STEPHEN M
Non-Executive Director
4,000 +11.1%
7.78
US$31,124 		4,000 +11.1% 7.78 US$31,124
2025-05-08 2025-05-06 B Purchase
3.1
Zook Anthony P.

Chief Executive Officer

Executive Director
18,900 +inf%
7.88
US$148,919 		18,900 +inf% 7.88 US$148,919
2025-05-07 2025-05-05 B Purchase
1.5
Perez David Brian
Non-Executive Director
10,000 +inf%
7.63
US$76,300 		10,000 +inf% 7.63 US$76,300
2025-05-07 2025-05-05 B Purchase
1.5
Gunn Neil
Non-Executive Director
4,510 +39.8%
7.76
US$34,977 		4,510 +39.8% 7.76 US$34,977
2025-05-06 2025-05-02 PP Planned purchase
3.4
Sherman Jeffrey Scott

Chief Financial Officer

Officer
20,000 +14.4%
7.51
US$150,104 		20,000 +14.4% 7.51 US$150,104
2024-11-19 2024-11-15 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
5,175 -12.2%
15.36
US$79,475 		5,175 -12.2% 15.36 US$79,475
2024-11-15 2024-11-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
5,175
15.79
US$81,713 		5,175 15.79 US$81,713
2024-08-19 2024-08-15 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
1,040 -2.3%
16.05
US$16,695 		1,040 -2.3% 16.05 US$16,695
2024-08-15 2024-08-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
1,040
15.82
US$16,453 		1,040 15.82 US$16,453
2024-08-15 2024-08-15 PrS Proposed sale
1.7
BRUCE K CROWTHER

Officer; Director

Executive Director
8,353
15.95
US$133,243 		8,353 15.95 US$133,243
2024-05-28 2024-05-28 PrS Proposed sale
1.7
BRUCE K CROWTHER

Officer; Director

Executive Director
13,882
14.29
US$198,336 		13,882 14.29 US$198,336
2024-05-17 2024-05-15 S Sale
1.8
Olivo Alicia C

General Counsel

Officer
1,049 -2.3%
15.74
US$16,511 		1,049 -2.3% 15.74 US$16,511
2024-05-15 2024-05-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
1,049
15.40
US$16,155 		1,049 15.40 US$16,155
2024-03-06 2024-03-04 S Sale
2.7
TETRAULT LYNN A.
Non-Executive Director
6,112 -10.9%
15.97
US$97,579 		6,112 -10.9% 15.97 US$97,579
2024-03-04 2024-03-04 PrS Proposed sale
2.7
LYNN TETRAULT

Director

Non-Executive Director
6,112
15.97
US$97,609 		6,112 15.97 US$97,609
2024-02-20 2024-02-15 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
2,587 -6.9%
14.96
US$38,713 		2,587 -6.9% 14.96 US$38,713
2024-02-15 2024-02-15 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
2,587
14.90
US$38,546 		2,587 14.90 US$38,546
2023-11-20 2023-11-17 PlS Planned sale
1.8
Olivo Alicia C

General Counsel

Officer
2,669 -6.7%
18.39
US$49,083 		2,669 -6.7% 18.39 US$49,083
2023-11-17 2023-11-17 PrS Proposed sale
1.8
ALICIA OLIVO

Officer

Officer
2,669
17.97
US$47,962 		2,669 17.97 US$47,962
2022-03-09 2022-03-07 PlS Planned sale
2.0
Bonello William

Chief Financial Officer

Officer
3,209 -3.2%
18.29
US$58,693 		3,209 -3.2% 18.29 US$58,693
2021-12-23 2021-12-21 PlS Planned sale
McKenzie Kathryn B

Chief Financial Officer

Officer
1,846 -13.6%
35.00
US$64,610 		1,846 -13.6% 35.00 US$64,610
2021-12-06 2021-12-06 B Purchase
0.7
Mallon Mark

Chief Executive Officer

Executive Director
17,000 +30.5%
30.63
US$520,710 		17,000 +30.5% 30.63 US$520,710
2021-11-26 2021-11-26 PlS Planned sale
Brown Douglas Matthew

Chief Strategy Officer

Officer
33,334 -74.1%
36.85
US$1,228,358 		33,334 -74.1% 36.85 US$1,228,358
2021-11-29 2021-11-24 PlS Planned sale
2.0
Bonello William

President, Informatics

Officer
25,000 -61.8%
37.13
US$928,250 		25,000 -61.8% 37.13 US$928,250
2021-11-26 2021-11-24 PlS Planned sale
Brown Douglas Matthew

Chief Strategy Officer

Officer
33,333 -42.6%
36.84
US$1,227,988 		33,333 -42.6% 36.84 US$1,227,988
2021-11-26 2021-11-23 PlS Planned sale
Brown Douglas Matthew

Chief Strategy Officer

Officer
33,333 -29.9%
37.19
US$1,239,654 		33,333 -29.9% 37.19 US$1,239,654
2021-06-10 2021-06-08 S Sale
1.7
CROWTHER BRUCE K
Non-Executive Director
20,734 -29.5%
41.46
US$859,632 		20,734 -29.5% 41.46 US$859,632
2021-06-04 2021-06-03 S Sale
2.1
CARDOZA GEORGE

President, Pharma Services

Officer
31,107 -15.0%
40.11
US$1,247,702 		31,107 -15.0% 40.11 US$1,247,702
2021-06-04 2021-06-02 S Sale
2.1
CARDOZA GEORGE

President, Pharma Services

Officer
169,230 -44.9%
40.39
US$6,835,200 		169,230 -44.9% 40.39 US$6,835,200
2020-12-15 2020-12-14 S Sale
2.0
Weiss Lawrence Martin

Chief Medical Officer

Officer
20,200 -16.7%
51.06
US$1,031,412 		20,200 -16.7% 51.06 US$1,031,412
2020-12-14 2020-12-14 S Sale
2.6
JONES STEVEN C
Non-Executive Director
25,000 -2.4%
51.67
US$1,291,750 		25,000 -2.4% 51.67 US$1,291,750
2020-12-14 2020-12-11 S Sale
2.6
JONES STEVEN C
Non-Executive Director
25,000 -2.4%
50.52
US$1,263,000 		25,000 -2.4% 50.52 US$1,263,000
2020-12-11 2020-12-11 S Sale
2.3
BALLIET JENNIFER

VP and Chief Culture Officer

Officer
15,000 -37.5%
49.99
US$749,850 		15,000 -37.5% 49.99 US$749,850
2020-12-14 2020-12-10 S Sale
2.6
JONES STEVEN C
Non-Executive Director
20,000 -1.9%
50.30
US$1,006,000 		20,000 -1.9% 50.30 US$1,006,000
2020-12-07 2020-12-07 S Sale
2.6
JONES STEVEN C
Non-Executive Director
45,658 -4.1%
49.45
US$2,257,788 		45,658 -4.1% 49.45 US$2,257,788
2020-12-07 2020-12-04 S Sale
2.6
JONES STEVEN C
Non-Executive Director
64,394 -5.5%
48.07
US$3,095,420 		64,394 -5.5% 48.07 US$3,095,420
2020-12-07 2020-12-04 S Sale
1.5
Johnson Kevin C
Non-Executive Director
24,683 -44.3%
47.88
US$1,181,822 		24,683 -44.3% 47.88 US$1,181,822
2020-12-07 2020-12-03 S Sale
2.6
JONES STEVEN C
Non-Executive Director
19,948 -1.7%
48.03
US$958,102 		19,948 -1.7% 48.03 US$958,102
2020-12-04 2020-12-02 S Sale
2.0
Bonello William

President, Informatics

Officer
8,000 -39.9%
46.80
US$374,400 		8,000 -39.9% 46.80 US$374,400
2020-11-25 2020-11-25 S Sale
2.1
CARDOZA GEORGE

President, Pharma Services

Officer
77,074 -17.2%
45.48
US$3,505,326 		77,074 -17.2% 45.48 US$3,505,326
2020-11-25 2020-11-24 S Sale
2.1
CARDOZA GEORGE

President, Pharma Services

Officer
52,926 -12.5%
45.19
US$2,391,726 		52,926 -12.5% 45.19 US$2,391,726
2020-11-18 2020-11-16 S Sale
1.4
HIPP RAYMOND R
Non-Executive Director
70,000 -51.2%
42.28
US$2,959,600 		70,000 -51.2% 42.28 US$2,959,600
2020-11-16 2020-11-16 S Sale
0.9
VAN OORT DOUGLAS M

Chairman and CEO

Executive Director
100,000 -4.0%
42.34
US$4,234,000 		100,000 -4.0% 42.34 US$4,234,000
2020-11-16 2020-11-13 S Sale
0.9
VAN OORT DOUGLAS M

Chairman and CEO

Executive Director
118,752 -4.5%
41.56
US$4,935,333 		118,752 -4.5% 41.56 US$4,935,333
2020-11-16 2020-11-12 S Sale
0.9
VAN OORT DOUGLAS M

Chairman and CEO

Executive Director
121,248 -5.1%
42.18
US$5,114,241 		121,248 -5.1% 42.18 US$5,114,241
2020-11-12 2020-11-10 S Sale
0.6
Pedulla Denise E

General Counsel

Officer
2,262 -3.8%
42.00
US$95,004 		2,262 -3.8% 42.00 US$95,004
2020-09-24 2020-09-24 S Sale
1.7
CROWTHER BRUCE K
Non-Executive Director
8,333 -15.2%
35.01
US$291,738 		8,333 -15.2% 35.01 US$291,738
2020-09-24 2020-09-22 S Sale
1.7
CROWTHER BRUCE K
Non-Executive Director
2,400 -4.9%
35.68
US$85,632 		2,400 -4.9% 35.68 US$85,632
2020-09-10 2020-09-10 S Sale
2.6
JONES STEVEN C
Non-Executive Director
37,991 -2.7%
37.13
US$1,410,606 		37,991 -2.7% 37.13 US$1,410,606
2020-09-10 2020-09-09 S Sale
2.6
JONES STEVEN C
Non-Executive Director
71,583 -4.8%
36.98
US$2,647,139 		71,583 -4.8% 36.98 US$2,647,139
2020-09-10 2020-09-08 S Sale
2.6
JONES STEVEN C
Non-Executive Director
10,426 -0.7%
36.13
US$376,691 		10,426 -0.7% 36.13 US$376,691
2020-08-10 2020-08-06 S Sale
2.1
CARDOZA GEORGE

President, Pharma Services

Officer
82,500 -19.0%
39.35
US$3,246,375 		82,500 -19.0% 39.35 US$3,246,375
2020-08-04 2020-08-03 S Sale
2.0
Bonello William

President, Informatics

Officer
22,000 -64.6%
38.61
US$849,420 		22,000 -64.6% 38.61 US$849,420
2020-08-04 2020-08-03 S Sale
2.3
BALLIET JENNIFER

VP and Chief Culture Officer

Officer
13,000 -34.2%
39.25
US$510,250 		13,000 -34.2% 39.25 US$510,250
2020-08-03 2020-07-30 S Sale
2.4
SHOVLIN ROBERT J.

President, Clinical Services

Officer
81,356 -35.4%
38.17
US$3,105,359 		81,356 -35.4% 38.17 US$3,105,359
2020-03-05 2020-03-04 S Sale
2.4
SHOVLIN ROBERT J.

President, Clinical Services

Officer
98,093 -39.3%
30.86
US$3,027,150 		98,093 -39.3% 30.86 US$3,027,150
2020-03-04 2020-03-02 S Sale
2.6
JONES STEVEN C
Non-Executive Director
20,000 -39.6%
28.24
US$564,800 		20,000 -39.6% 28.24 US$564,800
Explore more

More insider trading research around Neogenomics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America